Tag: trastuzumab

Latest News

New antibody-drug conjugate shows promising activity in salivary gland tumors

Newsemia
The antibody-drug conjugate ado-trastuzumab emtansine (T-DM1) has promising activity in HER2 amplified salivary gland tumors, according to data published in the Annals of Oncology. Source...
Latest News

Obesity linked to increased risk of cardiotoxicity in chemotherapy-treated patients with breast cancer

Newsemia
Anthracyclines remain a cornerstone of breast cancer therapy in combination with new-generation targeted drugs such as trastuzumab. Both types of drugs are major culprits in...
Latest News

Biosimilar for HER2+ breast cancer achieves similar overall response rate to reference drug

Newsemia
The trastuzumab biosimilar HLX02 achieved similar overall response rate to reference trastuzumab in women with human epidermal growth factor receptor 2-positive (HER2+) recurrent or previously...
Neurology

Fremanezumab May Reduce Attacks in Tough-to-Treat Migraine

Newsemia
The CGRP-targeting migraine-prevention drug fremanezumab is safe and effective in reducing migraines for patients who have failed up to four other therapies, new research shows....
Cardiology

Three-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growth factor receptor 2-positive breast cancer.

Newsemia
Related Articles Three-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growth...
Neurology

Off-Label Drug Research Generates 'Medical Uncertainty'

Newsemia
Research that explores/supports off-label use of pregabalin and other medications may be misleading if early promising results are not subsequently validated, investigators suggest in a...
Latest News

Samsung Bioepis gibt Ergebnisse einer zusätzlichen einjährigen Folgestudie bekannt, die das ereignisfreie Überleben mit dem SB3 Trastuzumab Biosimilar-Prüfpräparat mit Trastuzumab durch ADCC-Aktivität vergleicht

Newsemia
INCHEON, Korea–(BUSINESS WIRE)–Samsung Bioepis Co. Ltd. gab heute die Ergebnisse einer zusätzlichen einjährigen Folgestudie bekannt, in der das ereignisfreie Überleben (EFS) von SB3, einem Biosimilar-Prüfpräparat...
Latest News

Samsung Bioepis annonce les résultats d’une étude de suivi à un an supplémentaire, comparant la survie sans événement du SB3, candidat biosimilaire du trastuzumab, avec le trastuzumab de référence, en mesurant l’activité de l’ADCC

Newsemia
INCHEON, Corée–(BUSINESS WIRE)–Samsung Bioepis Co., Ltd. a annoncé aujourd’hui les résultats d’une étude de suivi à un an supplémentaire, comparant la survie sans événement (SSE) du SB3,...
Latest News

Riassunto: Samsung Bioepis comunica i risultati derivati da uno studio di follow-up aggiuntivo della durata di un anno in cui si è valutata la sopravvivenza senza eventi associata al candidato biosimilare di trastuzumab SB3 a fronte dell’originatore…

Newsemia
INCHEON, Corea–(BUSINESS WIRE)–Samsung Bioepis comunica i risultati derivati da uno studio di follow-up aggiuntivo della durata di un anno in cui si è valutata la...
Latest News

Samsung Bioepis Announces Results of Additional One-Year Follow-Up Study Comparing Event-Free Survival of SB3 Trastuzumab Biosimilar Candidate to Reference Trastuzumab by ADCC Activity

Newsemia
INCHEON, Korea–(BUSINESS WIRE)–Samsung Bioepis Co., Ltd. today announced the results of an additional one-year follow-up study comparing event-free survival (EFS) of SB3, a biosimilar candidate...
AI/ML

Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm.

Newsemia
Related Articles Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World